PIDOTIMOD A NEW EFFICIENT PRODUCT IN IMMUNOLOGICAL PROPHYLAXIS AND IMMUNOLOGICAL THERAPY OF RESPIRATORY INFECTIONS IN CHILDREN
The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and other medicat...
Main Author: | A.V. Karaulov |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1347 |
Similar Items
-
PIDOTIMOD A NEW EFFICIENT PRODUCT IN IMMUNOLOGICAL PROPHYLAXIS AND IMMUNOLOGICAL THERAPY OF RESPIRATORY INFECTIONS IN CHILDREN
by: A.V. Karaulov
Published: (2008-01-01) -
APPLICATION OF PIDOTIMOD FOR OFTEN RESPIRATORY INFECTIONS PROPHYLAXIS IN CHILDREN WITH ALLERGIC RESPIRATORY DISEASES
by: I. M. Gaiduk, et al.
Published: (2012-09-01) -
Interferons alpha and gamma, pidotimod, and tilorone in the treatment of acute respiratory infections in patients with allergic rhinitis: a prospective, cohort clinical and immunological study
by: O. V. Kalyuzhin, et al.
Published: (2022-07-01) -
SAFETY AND EFFECTIVENESS OF PIDOTIMOD IN ACUTE AND CHRONIC BRONCHITIS
by: A.V. Karaulov
Published: (2010-01-01) -
SAFETY AND EFFECTIVENESS OF PIDOTIMOD IN ACUTE AND CHRONIC BRONCHITIS
by: A.V. Karaulov
Published: (2010-11-01)